Apis Capital Advisors, LLC Oncternal Therapeutics, Inc. Transaction History

Apis Capital Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$3.37 - $4.76 $404,400 - $571,200	-120,000 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$4.75 - $9.39 $114,000 - $225,360	-24,000 Reduced 16.67%	120,000 $570,000
Q1 2021 May 14, 2021	SELL	$4.59 - $9.04 $165,240 - $325,439	-36,000 Reduced 20.0%	144,000 $1.2 Million
Q4 2020 Feb 16, 2021	BUY	$1.51 - $6.3 $271,800 - $1.13 Million	180,000 New	180,000 $882,000

362K

Ticker ONCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,517,200
Market Cap $29.4M
Description
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...

Get notified when there are updates to the investment portfolio of Apis Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Apis Capital Advisors, LLC with notifications on news.